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ABSTRACT
Background    Ultrasonographic homogeneity is an 
important differential finding between Warthin tumor 
and pleomorphic adenoma, two types of benign parotid 
gland tumors, with the former likely to be heterogeneous 
and the latter homogeneous. However, differences in the 
performance of ultrasound machines or the homogene-
ity cut-off level affect the judgment of ultrasonographic 
homogeneity. Therefore, in this study, we adopted a 
novel system for classifying the composition of tumors 
via ultrasonography, using anechoic area as a substitute 
for differences in homogeneity to differentiate between 
Warthin tumors and pleomorphic adenomas.
Methods    We evaluated 68 tumors that were histo-
pathologically diagnosed as Warthin tumor or pleomor-
phic adenoma between July 2009 and November 2015. 
Ultrasonographic images of the tumors were evaluated 
on the basis of key differentiating features, including 
features on B-mode imaging and color Doppler imaging. 
Additionally, the tumors were classified into four groups 
based on anechoic area, and findings were compared be-
tween Warthin tumors and pleomorphic adenomas.
Results    While 38 of the tumors were pleomorphic 
adenomas, 30 were Warthin tumors. The sensitivity, 
specificity, positive predictive value, negative predictive 
value, and diagnostic accuracy for detection of Warthin 
tumors using our novel classification system were 73.3%, 
76.3%, 71.0%, 78.4% and 75.0%, respectively. Compared 
to pleomorphic adenomas, Warthin tumors showed large 
or sponge-like anechoic areas, rich vascularization and 
an oval shape even at large tumor sizes, and the differ-
ence was significant. On defining Warthin tumor as a 
tumor demonstrating two or more of the findings noted 
above, the sensitivity, specificity, positive predictive 
value, negative predictive value and diagnostic accuracy 
for its detection were 73.3%, 84.2%, 78.6%, 80.0% and 
79.4%, respectively.
Conclusion    Our novel classification system based on 
anechoic area patterns demonstrated by the tumors had 
high sensitivity, specificity and diagnostic accuracy for 
differentiating Warthin tumors from pleomorphic ade-
nomas.
Key words    diagnostic imaging; parotid neoplasms; 
pleomorphic adenoma; ultrasonography; Warthin tumor
Approximately 80–90% of parotid gland tumors are 
benign, and the majority of these (80–95%) are pleo-
morphic adenomas or Warthin tumors,1–3 which require 
different treatment strategies. Malignant transformation 
occurs in 2–25% of pleomorphic adenomas,4, 5 and surgi-
cal removal is the preferable treatment for these tumors. 
In contrast, Warthin tumors can often be left untreated 
because malignant transformation is extremely rare. 
Therefore, it is important to differentiate between pleo-
morphic adenomas and Warthin tumors at the preopera-
tive stage.
 Ultrasonography (US) is more advantageous than 
computed tomography or magnetic resonance imaging 
because of its simplicity, low cost, non-invasiveness, 
and real-time images. Therefore, US is the first-line 
diagnostic imaging method for assessing parotid gland 
diseases.6 It would be ideal if it were possible to dif-
ferentiate between parotid gland tumors using US and 
decide if surgery were indicated. Over the last 20 years, 
many studies have therefore evaluated the usefulness of 
US in differentiating between pleomorphic adenomas 
and Warthin tumors of the parotid gland on the basis of 
shape, homogeneity, anechoic areas, and vasculariza-
tion.7–15
 Homogeneity is an important differential finding 
between the two types of tumor, with Warthin tumors 
likely to be heterogeneous and pleomorphic adenomas 
homogeneous. However, a wide range (20–91.9%) of 
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the proportion of homogeneous pleomorphic adenomas 
has been reported.7–14 It has been postulated that this is 
due to differences in the performance of ultrasound ma-
chines or in the homogeneity cut-off level.
 Therefore, in this study, we adopted a novel system 
for classifying the composition of tumors via US, using 
anechoic area patterns as a substitute for differences in 
homogeneity; we then evaluated the usefulness of this 




This was a retrospective study of consecutive patients 
who underwent US at the Department of Otorhinolar-
yngology-Head and Neck Surgery of Tottori University 
Hospital between July 2009 and November 2015, and 
whose histological diagnosis after resection of parotid 
gland tumors was either Warthin tumor or pleomorphic 
adenoma. Patients who did not undergo surgical resec-
tion were excluded; this is because parotid tumors have a 
variety of histopathological presentations, and sufficient 
diagnostic accuracy cannot be ensured using only cytol-
ogy. We also excluded one patient who suffered a recur-
rence and three patients whose preoperative US findings 
were inconclusive — these included patients with tumors 
either so large that they could not be fully visualized via 
US or that were located in the deep lobe of the parotid 
gland and were therefore difficult to visualize (Fig. 1).
 The study was approved by the Ethics Review Board 
of the Tottori University Faculty of Medicine (1510A064), 
and requirement for informed consent was waived be-
cause of the retrospective nature of the study. All proce-
dures were carry out in accordance with the Declaration 
of Helsinki of 1975, as revised in 2013.
Methods
The US images of the Warthin tumors and pleomorphic 
adenomas were compared and US findings characteristic 
of each type of tumor were examined. 
 
Assessment of the US images
US examinations were performed using a Xario XG Ul-
trasound System (Toshiba Medical Systems Corporation, 
Tochigi, Japan) until late October 2011 and an ACUSON 
S2000 Ultrasound System (Siemens Medical Solutions 
USA, Malvern, PA) from November 2011 onwards. The 
probe frequency range was 4–9 MHz. The images were 
assessed separately by a board-certified fellow of the 
Japan Society of Ultrasonics in Medicine (JSUM) and 
a JSUM registered medical sonographer, both of whom 
were blinded to histological findings and diagnoses of 
the tumors. If there were discrepancies between the find-
ings, a final decision was reached by consensus.
B-mode imaging
Images of the tumors were evaluated on the basis of the 
Fig 1. 	
Parotid tumor 
Surgery(+) and pathological 
diagnosis(+) 
90 patients Exclusions 
Other tissue-type 
・Benign tumors: 8 patients 
・Malignant tumors: 16 patients	
Warthin tumor 
24 patients, 30 tumors	
Pleomorphic adenoma 
42 patients, 43 tumors	
Exclusions 
・Inconclusive US: 3 patients 
・Recurrence: 1 patient	
Pleomorphic adenoma 
38 patients, 38 tumors	
Fig. 1. Flowchart of inclusion and exclusion criteria. US, ultrasonography.
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Fig. 2. Classifi cation based on anechoic area patterns.
following parameters: major axis, shape (oval or lobu-
lated/irregular), borders (well-defi ned or ill-defi ned), in-
ternal echo levels (hypoechoic, isoechoic or hyperechoic 
compared with normal parts of the gland) and presence 
or absence of posterior echo enhancement.
 In addition, the tumors were classified into four 
groups on the basis of anechoic area patterns on US: Tu-
mors with no anechoic areas were allocated to Group 1; 
tumors with one or a few small circular anechoic areas 
(< 3 mm) were allocated to Group 2; tumors with large 
anechoic areas and no sponge-like appearance were 
allocated to Group 3; and tumors with a sponge-like ap-
pearance, in which large and small anechoic areas were 
mixed finely within the solid part, were allocated to 
Group 4 (Fig. 2).
Doppler imaging
Vascularization of the tumors was evaluated according 
to three grades on the basis of the amount of fl ow sig-
nals on color Doppler imaging. Thus, tumors with no 
fl ow signal or with one or two punctiform fl ow signals 
were classifi ed as Grade 1; those with three to fi ve punc-
tiform or linear fl ow signals in or around the tumor were 
classifi ed as Grade 2; and those with more than fi ve fl ow 
signals in the entire area of the solid part of the tumor 
were classifi ed as Grade 3.
Statistical analysis
Non-normally distributed continuous data were ex-
pressed as median [range], and categorical data as n 
(%). SPSS Statistics for windows, version 22.0 (IBM, 
Armonk, NY) was used for all statistical analyses. For 
continuous variables, the Mann-Whitney U test was 
used to compare differences between the two groups, 
and all continuous variables were expressed as the me-
dian and range. The Chi-Square test or Fisher’s exact 
test was used to compare categorical variables, and all 
categorical variables were expressed as numbers and 
percentages. A P-value < 0.05 was considered statistical-
ly signifi cant.
Table 1. Patient data
Warthin tumor Pleomorphic adenoma
Patients (n) 24 38
Age (years) 55 (46–80) 65 (28–80)
Sex (men/women) 19/5 12/26
Median [range].
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RESULTS
A total of 62 patients were included in the study, 24 with 
Warthin tumors and 38 with pleomorphic adenomas. 
Among the 24 patients with Warthin tumors, two had 
two tumors and two had three tumors. Table 1 shows 
the demographic and clinical characteristics of all pa-
tients by diagnosis. The median age of participants with 
Warthin tumors was 55 years (range, 46 to 80 years) and 
19 participants were men; the median age of those with 
pleomorphic adenomas was 65 years (range, 28 to 80 
years) and 12 were men. 
Table 2. Gray-scale ultrasonographic (US) features of Warthin tumors and pleomorphic adenomas of the parotid 
gland
US features Warthin tumor Pleomorphic adenoma P-values
Tumors (n) 30 38
Diameter (mm) 30.5 (16.7–46.3) 22.4 (9.3–52.0) 0.008**
Shape 0.012*
Oval 21 (70.0%) 15 (39.5%)
Lobulated/irregular 9 (30.0%) 23 (60.5%)
Border 1.000
Well-defined 30 (100%) 37 (97.4%)
Ill-defined 0 (0%) 1 (2.6%)
Internal echo level  1.000
Hypoechoic 29 (96.7%) 37 (97.4%)
Isoechoic 1 (3.3%) 1 (2.6%)
Hyperechoic 0 (0%) 0 (0%)
Posterior echo enhancement  0.500
Yes 30 (100%) 36 (94.7%)
No 0 (0%) 2 (5.3%)
Median [range]; *P < 0.05; **P < 0.01.  
Table 3. Classification based on anechoic area patterns on ultraso-
nography (US)  
US feature Warthin tumor Pleomorphic adenoma P-value
Anechoic areas < 0.001***
Group 1 6 (20.0%) 24 (63.2%)
Group 2 2 (6.7%) 5 (13.2%)
Group 3 6 (20.0%) 7 (18.4%)
Group 4 16 (53.3%) 2 (5.3%)
***P < 0.001.
Table 4. Doppler-mode ultrasonographic (US) features of Warthin tu-
mors and pleomorphic adenomas of the parotid gland
US feature Warthin tumor Pleomorphic adenoma P-value
Vascularization  < 0.001***
Grade 1 10 (33.3%) 30 (78.9%)
Grade 2 7 (23.3%) 5 (13.2%)
Grade 3 13 (43.3%) 3 (7.9%)
***P < 0.001.
 A total of 68 tumors were included in 
the study; 30 Warthin tumors and 38 
pleomorphic adenomas. The findings 
from the B-mode images are shown in 
Table 2. 
 The median value of the major axis 
was 30.5 mm (range, 16.7 to 46.3 mm) 
for Warthin tumors and 22.4 mm (range, 
9.3 to 52.0 mm) for pleomorphic ade-
nomas (P = 0.008). Morphologically, 
70.0% of Warthin tumors were oval, 
whereas 60.5% of pleomorphic adeno-
mas were lobulated (P = 0.012). Assum-
ing that an oval shape was characteristic 
of Warthin tumor, the sensitivity, spec-
ificity, and diagnostic accuracy for de-
tection of this tumor were 70.0%, 60.5% 
and 64.7%, respectively. There was 
no difference in clarity of the borders, 
internal echo levels, or posterior echo 
enhancement between the two types of tumors.
 Based on anechoic area patterns, 20.0% of Warthin 
tumors and 63.2% of pleomorphic adenomas were clas-
sified as Group 1, 6.7% of Warthin tumors and 13.2% of 
pleomorphic adenomas as Group 2, 20.0% of Warthin 
tumors and 18.4% of pleomorphic adenomas as Group 3, 
and 53.3% of Warthin tumors and 5.3% of pleomorphic 
adenomas as Group 4; there were significant differences 
between the groups (P < 0.001) (Table 3). 
 Assuming that tumors in Groups 3 and 4 had fea-
tures characteristic of Warthin tumors, the sensitivity, 
specificity, positive predictive value, negative predictive 
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Table 5. Diagnostic accuracy of each ultrasonographic (US) feature differentiating Warthin tumors from pleo-
morphic adenomas
US features Sensitivity Specificity PPV NPV Accuracy
Shape 70.0% 60.5% 58.3% 71.9% 64.7%
Anechoic area pattern 73.3% 76.3% 71.0% 78.4% 75.0%
Vascularization 66.7% 78.9% 71.4% 75.0% 73.5%
Presence of two or more than two features 73.3% 84.2% 78.6% 80.0% 79.4%











Fig. 3. Ultrasonography images of a pleo-
morphic adenoma: macroscopic/histological 
findings of resected specimens. Note the 
lobulated shape of the tumor, without an-
echoic area and one linear flow signal (a, 
b). Macroscopic findings of the resected 
specimen show a well-defined boundary 
with the surrounding tissues; the sectioned 
surface is glossy, and the tumor is solid (c). 
Histological findings show that the tumor 
is covered with a fibrous capsule and that 
the tumor content is solid, but mixed with 
epithelial components, myxomatous stroma, 
and cartilaginous matrix-like stroma (d).
value, and diagnostic accuracy for detection of Warthin 
tumor in our study were 73.3%, 76.3%, 71.0%, 78.4% 
and 75.0%, respectively.
 The results of evaluation of the differences in vascu-
larization were as follows: Grade 1 in 33.3% and 78.9% 
of Warthin tumors and pleomorphic adenomas, respec-
tively; Grade 2 in 23.3% and 13.2%, respectively; and 
Grade 3 in 43.3% and 7.9%, respectively. This indicates 
that vascularization was significantly more abundant in 
the Warthin tumors (P < 0.001) (Table 4). 
 Assuming Grade 2 vascularization or above was 
characteristic of Warthin tumors, the sensitivity, speci-
ficity, and diagnostic accuracy for detection of Warthin 
tumor were 66.7%, 78.9% and 73.5%, respectively.
 The most useful ultrasonographic findings for dif-
ferentiating between Warthin tumors and pleomorphic 
adenomas were the tumor’s shape, anechoic area pattern, 
and vascularization. (Figs. 3 and 4) When we defined 
Warthin tumor as that satisfied two or more of the find-
ings noted above, the sensitivity, specificity, positive pre-
dictive value, negative predictive value and diagnostic 
accuracy for detection of Warthin tumors were 73.3%, 
84.2%, 78.6%, 80.0% and 79.4%, respectively (Table 5). 
DISCUSSION
Although the level of homogeneity within parotid tu-
mors has been a useful characteristic for differentiating 
Warthin tumors from pleomorphic adenomas using US,7 
the range of reported homogeneity varies between 20% 
and 91.9%,7–14 and the proportion of homogeneous  pleo-
morphic adenomas was higher more than 15 years ago 
compared to that in recent reports.7 This supports the 
postulation that the performance of ultrasound machine 
has an effect on assessment of levels of homogeneity of 
pleomorphic adenomas as new ultrasound machines, 
which have higher resolution, can enable visualization 
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of the pathological heterogeneity of the internal archi-
tecture of pleomorphic adenomas. This is thought to be 
another reason for the wide range of frequencies of ho-
mogeneous pleomorphic adenomas among recent stud-
ies, as the degree of homogeneity that marks the cut-off 
level is determined by subjective assessment of the US 
image. In addition, it is difficult to assess homogeneity 
of the solid parts via gray-scale US when the tumor has 
mixed content that includes many small solid parts and 
spongiform cysts as solid parts may be too small for as-
sessment.
 For these reasons, in this study, we assessed the 
sonographic composition of tumors using anechoic area 
patterns rather than sonographic homogeneity. We clas-
sified 76.3% of pleomorphic adenomas as Group 1 or 2 
because they were characterized by no anechoic areas 
or a few small circular anechoic areas. Our classification 
is supported by previous studies that have reported that 
pleomorphic adenomas are characterized mainly by an 
absence of anechoic areas or presence of a small an-
echoic area.9 Further, we classified 73.3% of the Warthin 
tumors as Group 3 or 4 based on their anechoic area 
patterns; these tumors were characterized by large or 
sponge-like anechoic areas. Some studies have reported 
















Fig. 4. Ultrasonography images of a 
Warthin tumor: macroscopic/histolog-
ical findings of resected specimens. 
Note the tumor contains many large 
and small anechoic areas; additional-
ly, a large number of punctiform and 
linear flow signals can be seen in the 
solid part of the tumor (a, b). Macro-
scopic findings show that the solid and 
cystic parts of the tumor are mixed 
together (c). Note that the solid parts 
of the tumor contain dense epithelial 
cells and that the cystic parts of the 
tumor are of various sizes (d).
44.8–93.3%;7, 8, 10, 11, 14 in one study, for example, 96.6% 
of Warthin tumors contained pathologically identified 
cystic lesions.11 However, the diagnostic accuracy using 
anechoic areas or sponge-like anechoic areas as charac-
teristic features of Warthin tumor has been reported to 
be 44.4–56.3%,11, 14 which was not high enough. In con-
trast, our novel classification system based on anechoic 
area patterns of tumor content has demonstrated high 
diagnostic accuracy for differentiating Warthin tumors 
from pleomorphic adenomas.
 When we measured the tumors, we found that the 
diameters of Warthin tumors were significantly larger 
than those of pleomorphic adenomas. However, this 
result may be subject to bias because the tumors in this 
study were from operated patients; surgery often was 
not indicated for small Warthin tumors, which were 
therefore excluded from this study, while pleomorphic 
adenomas were resected even if they were small. For 
this reason, tumor diameter was not used to differentiate 
Warthin tumors from pleomorphic adenomas on US.
 Pleomorphic adenomas have been found to be more 
likely to have a lobulated shape when their diameter 
exceeds approximately 20 mm;16 in our study, large 
pleomorphic adenomas also tended to have a lobulated 
shape. In contrast, we found that Warthin tumors were 
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oval shaped even when they had a large size. This find-
ing was similar to those in previous studies.9–11, 13
 We also found that the vascularization within War-
thin tumors was significantly richer than that in pleo-
morphic adenomas. This finding was also similar to 
those in previous studies.12–14 In one study, microvessels 
were found to be less numerous in pleomorphic ade-
nomas, and Warthin tumors had higher cellularity and 
microvessel density than pleomorphic adenomas.17 How-
ever, a few pleomorphic adenomas had rich vascularity 
in our study. This apparent disparity can be explained 
by findings from some studies that vascularity is rich in 
the presence of abundant cellular components but that it 
decreases in the presence of abundant myxomatous stro-
ma.17
 There were several limitations of this study. First, 
this was a retrospective study and thus US features were 
not evaluated in real time. Second, the sample size was 
small, with only 68 tumors; further, larger studies are 
required. Third, this study was limited to pleomorphic 
adenomas and Warthin tumors of the parotid gland; 
therefore, other benign and malignant tumors, albeit 
comparatively rare, were excluded. Fourth, we relied 
on the accuracy of pathological diagnosis and excluded 
patients who had not undergone surgery; therefore, ap-
proximately half of the patients with suspected Warthin 
tumors were excluded.
 In conclusion, our novel classification system based 
on anechoic area patterns of the content of tumors had 
high sensitivity, high specificity and diagnostic accuracy 
for differentiating Warthin tumors from pleomorphic 
adenomas. Furthermore, the combination of two or more 
ultrasonographic findings (relating to anechoic area pat-
terns, shape, and vascularization) may improve diagnos-
tic accuracy when differentiating Warthin tumors from 
pleomorphic adenomas and has considerable advantages 
over previous diagnostic systems.
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